The Oncology Drugs Market is experiencing explosive growth, propelled most powerfully by the commercialization of sophisticated Cell and Gene Therapies (CGTs). These therapies, such as CAR T-cell treatments, represent a fundamental departure from traditional small molecule and antibody drugs, offering potentially curative results by genetically modifying a patient’s own immune cells to...